期刊文献+

NUDT15c.415C>T和TPMT*3C基因多态性检测方法的比较与临床应用

Comparison and Clinical Application of Genotyping Approaches for Azoioprine Induced Leukocyte Reduction Alleles NUTT15C.415C>T and TPMT*3C
原文传递
导出
摘要 目的建立准确、快速、经济的方法,检测NUDT15 c.415C>T和TPMT*3C基因多态性,探讨临床应用价值。方法收集2017年5月—2018年5月期间福建汉族患者服用硫唑嘌呤2周以上的血清样本,提取DNA或白细胞后分别采用PCR-RFLP法、PCR-Sanger测序法和荧光定量PCR法对NUDT15c.415C>T和TPMT*3C进行基因多态性分型,比较这3种方法的准确性、简便性及经济性。根据白细胞值分组,结合临床资料,探讨基因多态性等因素与硫唑嘌呤致白细胞减少的相关性。结果共纳入129例患者,其中硫唑嘌呤致白细胞减少15例(11.6%)。3种方法的基因多态性检测结果一致,TPMT*3C未发现突变纯合子。携带NUDT15c.415C>T突变等位基因者服用硫唑嘌呤致白细胞减少的风险高于携带野生等位基因者(OR=6.2,95%CI:2.5~15.4,P=0.000 054),而携带TPMT*3C突变等位基因者与野生等位基因者出现白细胞减少比例并无显著性差异(P=0.393)。NUDT15c.415C>T基因多态性预测白细胞减少敏感度为53.3%,特异度为85.1%,ROC曲线AUC为0.69。结论 3种方法都可用于临床检测NUDT15 c.415C>T和TPMT*3C基因多态性。PCR-RFLP法不需要专用试剂盒,也不需要昂贵的仪器设备,成本较低,过程简单,易于操作,特别适合条件有限的单位开展工作。福建汉族患者在服用硫唑嘌呤前进行NUDT15c.415C>T基因多态性检测比TPMT*3C更具临床价值。 OBJECTIVE To establish an accurate, rapid and economical method for detecting NUDT15 c.415C>T and TPMT*3C gene polymorphisms and evaluate the value of their clinical application. METHODS Serum samples of patients taking azathioprine for more than 2 weeks from May 2017 to May 2018 in Fujian were collected. NUDT15 c.415C>T and TPMT*3C were genotyping by PCR-restriction fragment length polymorphism (PCR-RFLP), PCR-Sanger, and real-time PCR. The accuracy, simplicity and economy of the three methods were compared. The association between genetic polymorphisms and azathioprine-induced leukocyte reduction was analyzed in combination with clinical data. RESULTS A total of 129 patients were included, 15 (11.6%) of whom developed leukopenia. The results of the methods were essentially equivalent. No mutant homozygote genotype was found in TPMT*3C gene. There was strong associations of NUDT15 c.415C>T with azathioprine-induced leukopenia (OR=6.2, 95%CI:2.5~15.4, P=0.000 054), whereas there was no relevance for TPMT*3C (P=0.393). The predictive sensitivity of NUDT15 c.415C>T was 53.3%,specificity was 85.1%, and AUC of ROC curve was 0.69. CONCLUSION The three methods can be used for clinical detection of NUDT15 c.415C>T and TPMT*3C gene polymorphisms. The PCR-RFLP method does not require special kit, no expensive equipment, low cost, simple process, easy operability, and especially applicable to the basic medical institutions or scientific research units with limited conditions. The detection of NUDT15c.415C>T gene polymorphisms for Fujian Han patients with azathioprine has better clinical value than the detection of TMPT*3C.
作者 曾大勇 董家珊 王长连 黄品芳 林荣芳 刘亦伟 ZENG Dayong;DONG Jiashan;WANG Changlian;HUANG Pinfang;LIN Rongfang;LIU Yiwei(Department of Pharmacy, The First Affiliated Hospital of Fujian Medical University, Fuzhou 350005, China)
出处 《中国现代应用药学》 CAS CSCD 北大核心 2019年第9期1102-1106,共5页 Chinese Journal of Modern Applied Pharmacy
基金 福建省卫生计生中青年骨干人才培养项目(2016-ZQN-38) 福建省卫生计生科研人才培养项目资助(2018-ZQN-53)
关键词 硫唑嘌呤 白细胞减少 NUDT15c.415C>T TPMT*3C 基因多态性检测 azathioprine leukocyte NUDT15 c.415C>T TPMT*3C gene polymorphism detection
  • 相关文献

参考文献2

二级参考文献12

  • 1Lennard L, Singleton HJ. High-performance liquid chromatographic assay of human red blood cell thiopurine methyhransferase activity. J Chromatogr B Biomed Appl, 1994, 661 : 25-33. 被引量:1
  • 2Ganiere-Monteil C, Pineau A, Kergueris MF, et al. Thiopurine methyl transferase activity: new extraction conditions for high-pedormance liquid chromatographic assay. J Chromatogr B Biomed Sci Appl, 1999, 727: 235-239. 被引量:1
  • 3Coulthard SA, Matheson EC, Hall AG, et al. The clinical impact of thiopurine methyltransferase polymorphisms on thiopurine treatment.Nucleosides Nucleotides Nucleic Acids, 2004, 23:1385-1391. 被引量:1
  • 4Iyer L, Ratain MJ. Pharmacogenetics and cancer chemotherapy. Eur J Cancer, 1998, 34 : 1493-1499. 被引量:1
  • 5Stanulla M, Schaeffeler E, Flohr T, et al. Thiopurine methyltransferase (TPMT) genotype and early treatment response to mercaptopurine in childhood acute lymphoblastie leukemia. JAMA,2005, 293 : 1485-1489. 被引量:1
  • 6MeLeod HL, Coulthard S, Thomas AE, et al. Analysis of thiopurine methyltransferase variant alleles in childhood acute lymphoblastic leukaemia. Br J Haematol, 1999, 105:696-700. 被引量:1
  • 7Weinshilboum R. Thiopurine pharmacogeneties : clinical and molecular studies of thiopurine methyhransferase. Drug Metab Dispos, 2001, 29:601-605. 被引量:1
  • 8Keuzenkamp-Jansen CW, Leegwater PA, De Abreu RA, et al.Thiopurine methyltransferase: a review and a clinical pilot study. J Chromatogr B Biomed Appl, 1996, 678 : 15-22. 被引量:1
  • 9McLeod HL, Lin JS, Scott EP, et al. Thiopurine methyltransferase activity in American white subjects and black subjects. Clin Pharmacol Ther, 1994, 55 : 15-20. 被引量:1
  • 10Capdeville R, Mousson B, Bax G, et al. Interactions between 6-mercaptopurine therapy and thiopurine-methyl-transferase (TPMT)activity. Eur J Clin Pharmacol, 1994, 46 : 385-386. 被引量:1

共引文献25

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部